Other parameters collected show that HIV+ persons in the current cohort had less OPC, less antifungal use, higher blood CD4 cell counts, and a lower incidence of xerostomia, across age, race, and sex, compared to the previous HIV+ cohort (Table 3). The gene discussed is CD4; the disease is xerostomia.